- Home
- SNTI vs PED Comparison
SNTI vs PED Comparison
Compare SNTI & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNTI | PED |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.6M | 54.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SNTI | PED |
|---|---|---|
| Price | $1.23 | $0.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $9.00 | $1.50 |
| AVG Volume (30 Days) | ★ 4.1M | 169.0K |
| Earning Date | 11-13-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.43 |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $33,244,999.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $150.00 | $305.89 |
| P/E Ratio | ★ N/A | $5.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.26 | $0.43 |
| 52 Week High | $5.96 | $1.00 |
Technical Indicators
Market Signals| Indicator | SNTI | PED |
|---|---|---|
| Relative Strength Index (RSI) | 33.44 | 52.73 |
| Support Level | $1.34 | $0.55 |
| Resistance Level | $2.88 | $0.61 |
| Average True Range (ATR) | 0.24 | 0.04 |
| MACD | -0.10 | 0.01 |
| Stochastic Oscillator | 0.62 | 71.03 |
Price Performance
Historical ComparisonAbout SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.